Lv. Buchanan et al., COMPARATIVE-ASSESSMENT OF IBUTILIDE, D-SOTALOL, CLOFILIUM, E-4031, AND UK-68,798 IN A RABBIT MODEL OF PROARRHYTHMIA, Journal of cardiovascular pharmacology, 22(4), 1993, pp. 540-549
Class III agents have been associated with development of a polymorphi
c ventricular tachycardia (PVT) known as torsades de pointes. We compa
red the class III agent ibutilide, which prolongs repolarization throu
gh enhancement of an inward sodium current, with the potassium channel
blockers E-4031, UK-68,798, clofilium, and D-sotalol for proarrhythmi
c effects in an anesthetized rabbit model. In these animals, prolongat
ion of repolarization during alpha1 stimulation with methoxamine produ
ces early after depolarizations (EADs) and a pause-dependent torsades
de pointes-like PVT. Agents were compared over dosage ranges that prod
uced maximal increases in QTc interval and monophasic action potential
duration (MAPD). PVT typically developed after atrio-ventricular (A-V
) conduction block and slowing of heart rate (HR), and was preceded by
development of repolarization arrhythmias characterized by EADs and t
riggered activity producing extrasystolic beats. Ibutilide administrat
ion resulted in significantly lower EAD amplitudes and a lower inciden
ce of repolarization arrhythmias and PVT as compared with administrati
on of other class III agents. The percentage of rabbits developing PVT
for each agent was ibutilide 12%, D-sotalol 70%, E-4031 56%, UK-68,79
8 69%, and clofilium 80%. Rabbits receiving saline vehicle instead of
a class III agent never developed conduction or repolarization abnorma
lities or PVT. Under the conditions of this study at doses that genera
te maximal class III effects, ibutilide produces lesser increases in Q
Tc interval and MAPD, and EADs of lower amplitude, resulting in a lowe
r incidence of repolarization arrhythmias and PVT as compared with oth
er class III agents.